Literature DB >> 26156512

Aerobic training and postexercise protein in facioscapulohumeral muscular dystrophy: RCT study.

Grete Andersen1, Kira P Prahm2, Julia R Dahlqvist2, Gülsenay Citirak2, John Vissing2.   

Abstract

OBJECTIVE: To investigate the effect of regular aerobic training and postexercise protein-carbohydrate supplementation in patients with facioscapulohumeral muscular dystrophy (FSHD).
METHODS: In this randomized, double-blind, placebo-controlled parallel study, we randomized untrained men (n = 21) and women (n = 20) with FSHD (age 19-65 years) to 2 training groups-training with protein supplement (n = 18) and training with placebo supplement (n = 13)-and a nonintervention control group (n = 10). We assessed fitness, walking speed, muscle strength, questionnaires, and daily activity levels before and after 12 weeks of interventions. Training involved 36 sessions of 30-minute cycle-ergometer training. After each session, patients drank either a protein-carbohydrate or placebo beverage.
RESULTS: In the trained participants, fitness, workload, and walking speed improved (10% [confidence interval (CI) 4%-15%], 18% [CI 10%-26%], 7% [CI 4%-11%], respectively, p < 0.001, number needed to treat = 2.1). Self-assessed physical capacity and health (Short Form-36) also improved. Muscle strength and daily activity levels did not change with training. Protein-carbohydrate supplementation did not result in further improvements in any tests compared to training alone.
CONCLUSIONS: This randomized, controlled study showed that regular endurance training improves fitness, walking speed, and self-assessed health in patients with FSHD without causing muscle damage. Postexercise protein-carbohydrate supplementation does not add any further improvement to training effects alone. CLASSIFICATION OF EVIDENCE: This study provides Class II evidence that regular aerobic training with or without postexercise protein-carbohydrate supplementation improves fitness and workload in patients with FSHD.
© 2015 American Academy of Neurology.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26156512     DOI: 10.1212/WNL.0000000000001808

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  17 in total

Review 1.  Nutrition and exercise in Pompe disease.

Authors:  Mark A Tarnopolsky; Mats I Nilsson
Journal:  Ann Transl Med       Date:  2019-07

Review 2.  Facioscapulohumeral Dystrophy.

Authors:  Leo H Wang; Rabi Tawil
Journal:  Curr Neurol Neurosci Rep       Date:  2016-07       Impact factor: 5.081

3.  MRI as outcome measure in facioscapulohumeral muscular dystrophy: 1-year follow-up of 45 patients.

Authors:  Grete Andersen; Julia R Dahlqvist; Christoffer R Vissing; Karen Heje; Carsten Thomsen; John Vissing
Journal:  J Neurol       Date:  2016-12-20       Impact factor: 4.849

4.  High-intensity interval training in facioscapulohumeral muscular dystrophy type 1: a randomized clinical trial.

Authors:  Grete Andersen; Karen Heje; Astrid Emile Buch; John Vissing
Journal:  J Neurol       Date:  2017-05-03       Impact factor: 4.849

Review 5.  Strength training and aerobic exercise training for muscle disease.

Authors:  Nicoline Bm Voet; Elly L van der Kooi; Baziel Gm van Engelen; Alexander Ch Geurts
Journal:  Cochrane Database Syst Rev       Date:  2019-12-06

Review 6.  Exercise Therapy in Spinobulbar Muscular Atrophy and Other Neuromuscular Disorders.

Authors:  Julia Rebecka Dahlqvist; John Vissing
Journal:  J Mol Neurosci       Date:  2015-11-19       Impact factor: 3.444

7.  Interventions for promoting physical activity in people with neuromuscular disease.

Authors:  Katherine Jones; Fiona Hawke; Jane Newman; James Al Miller; Joshua Burns; Djordje G Jakovljevic; Grainne Gorman; Douglass M Turnbull; Gita Ramdharry
Journal:  Cochrane Database Syst Rev       Date:  2021-05-24

8.  Safety and efficacy of a 6-month home-based exercise program in patients with facioscapulohumeral muscular dystrophy: A randomized controlled trial.

Authors:  Landry-Cyrille Bankolé; Guillaume Y Millet; John Temesi; Damien Bachasson; Marion Ravelojaona; Bernard Wuyam; Samuel Verges; Elodie Ponsot; Jean-Christophe Antoine; Fawzi Kadi; Léonard Féasson
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

9.  Surgical correction of hyperlordosis in facioscapulohumeral muscular dystrophy: A case report.

Authors:  Haining Tan; Fan Feng; Youxi Lin; Chong Chen; Zheng Li; Jianxiong Shen
Journal:  BMC Surg       Date:  2017-07-17       Impact factor: 2.102

Review 10.  The prospects of targeting DUX4 in facioscapulohumeral muscular dystrophy.

Authors:  Linde F Bouwman; Silvère M van der Maarel; Jessica C de Greef
Journal:  Curr Opin Neurol       Date:  2020-10       Impact factor: 6.283

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.